While there are studies underway to characterize the direct effects of the COVID-19 pandemic on the care of patients with cancer, there have been relatively few quantitative reports of the impact that efforts to control the pandemic have had on the normal course of cancer diagnosis and treatment encounters. However, a multicenter research team led by Jack London, PhD, research professor emeritus of cancer biology, and Christopher McNair, PhD, associate director for data science at Sidney Kimmel Cancer Center and assistant professor of cancer biology, is studying that now. They have used encounter data from 20 healthcare institutions to compare numbers of cancer-related patient encounters in early 2019 to those occurring between January and April 2020, as COVID-19 became a pandemic.
"COVID’s Impact on Cancer Diagnosis,"
Thomas Jefferson University Research Magazine: Vol. 2:
1, Article 6.
Available at: https://jdc.jefferson.edu/researchmagazine/vol2/iss1/6